ITCMDBv1
Clinical TrialID 2583

Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis

NCT00619203

Bacterial Meningitis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2583
Evidence Id
2583
Core Evidence Id
2583
Source Clinical Trial Id
2562
Herb2 Clinical Trial Id
HBCT002562
Nct Id
NCT00619203
Title
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Status
Completed
Phase
Phase 3
Study Result
No
Study Condition
Bacterial Meningitis
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Glycerol and paracetamol|DRUG: Paracetamol|DRUG: Paracetamol|DRUG: Paracetamol|DRUG: Placebo|DRUG: Paracetamol and glycerol|DRUG: Glycerol
Intervention Allocation
Randomized
Intervention Model
Factorial
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Child
Enrollment
466
Outcome Measure
Primary end points are death, severe neurological sequelae, hearing loss., 2008-2011
Sponsor Collaborator
Kamuzu University of Health Sciences
Funded By
OTHER
Location
College of Medicine, Queen Elizabeth Central Hospital, Blantyre, 3, Malawi
Other Id
P.03/07/499
Start Date
2008-03
Primary Completion Date
2012-03
Completion Date
2012-03
First Posted
2008-02-20
Results First Posted
Last Update Posted
2012-07-10
Study Document
Study Url
https://clinicaltrials.gov/study/NCT00619203
Title Cn
Title En
Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Bilingual Status
semi_complete